Ekso Bionics Holdings, Inc. Common Stock (EKSO) is a publicly traded Healthcare sector company. As of May 21, 2026, EKSO trades at $11.80 with a market cap of $42.05M and a P/E ratio of -2.40. EKSO moved -3.56% today. Year to date, EKSO is +151.06%; over the trailing twelve months it is +62.87%. Its 52-week range spans $2.73 to $18.15. Rallies surfaces EKSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EKSO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EKSO recently traded at $11.80. Market cap is $42.05M. P/E ratio is -2.40. Revenue is $12.80M.
| Metric | Value |
|---|---|
| Price | $11.80 |
| Market Cap | $42.05M |
| P/E Ratio | -2.40 |
| EPS | $-4.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.15 |
| 52-Week Low | $2.73 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $12.80M |
| Net Income | $-11.70M |
| Gross Margin | 53.48% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $12.80M | $-11.70M | $-4.91 |
| 2023 | $18.28M | $-15.20M | $-1.10 |
| 2022 | $12.91M | $-15.08M | $-1.16 |
| 2021 | $11.25M | $-9.76M | $-0.80 |
EKSO analyst coverage data. Average price target: $0.00.